Kimberly-Clark Corporation (KMB)vs22nd Century Group Inc (XXII)
KMB
Kimberly-Clark Corporation
$98.43
+2.42%
CONSUMER DEFENSIVE · Cap: $31.90B
XXII
22nd Century Group Inc
$1.56
-3.11%
CONSUMER DEFENSIVE · Cap: $1.20M
Smart Verdict
WallStSmart Research — data-driven comparison
Kimberly-Clark Corporation generates 234770% more annual revenue ($16.56B vs $7.05M). KMB leads profitability with a 12.8% profit margin vs -71.7%. KMB earns a higher WallStSmart Score of 63/100 (C+).
KMB
Buy63
out of 100
Grade: C+
XXII
Avoid31
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-19.0%
Fair Value
$90.45
Current Price
$98.43
$7.98 premium
Margin of Safety
+70.6%
Fair Value
$19.09
Current Price
$1.56
$17.53 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 112 in profit
Reasonable price relative to book value
Areas to Watch
Expensive relative to growth rate
2.7% revenue growth
Weak financial health signals
Trading at 21.7x book value
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -116.6% — below average capital efficiency
Revenue declined 43.1%
Comparative Analysis Report
WallStSmart ResearchBull Case : KMB
The strongest argument for KMB centers on Return on Equity.
Bull Case : XXII
The strongest argument for XXII centers on Price/Book.
Bear Case : KMB
The primary concerns for KMB are PEG Ratio, Revenue Growth, Piotroski F-Score. Debt-to-equity of 4.77 is elevated, increasing financial risk.
Bear Case : XXII
The primary concerns for XXII are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
KMB profiles as a value stock while XXII is a turnaround play — different risk/reward profiles.
XXII carries more volatility with a beta of 1.12 — expect wider price swings.
KMB is growing revenue faster at 2.7% — sustainability is the question.
KMB generates stronger free cash flow (575M), providing more financial flexibility.
Bottom Line
KMB scores higher overall (63/100 vs 31/100). XXII offers better value entry with a 70.6% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Kimberly-Clark Corporation
CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA
Kimberly-Clark Corporation is an American multinational personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.
Visit Website →22nd Century Group Inc
CONSUMER DEFENSIVE · TOBACCO · USA
22nd Century Group Inc (Ticker: XXII) is an innovative biopharmaceutical and agricultural company dedicated to tobacco harm reduction through advanced genetic engineering techniques. By focusing on the development of low-nicotine tobacco products, the firm aims to mitigate nicotine addiction while enhancing public health outcomes. As it strategically diversifies into the burgeoning hemp and cannabis markets, 22nd Century positions itself to capitalize on the expanding legal cannabis landscape. With a robust commitment to scientific research and adherence to regulatory frameworks, the company represents a compelling investment opportunity for institutional investors looking to engage in transformative sectors.
Compare with Other HOUSEHOLD & PERSONAL PRODUCTS Stocks
Want to dig deeper into these stocks?